Done deal: Pfizer completes $43B acquisition of Seagen, doubling its oncology pipeline Pfizer’s $43 billion acquisition of Seagen is in the books, the company said on Thursday, as it becomes the largest M&A transaction in the biopharma industry since AbbVie snatched up Allergan for $63 billion in 2019. Log in or register to post comments
